Related Experiment Video

Updated: May 17, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

[Prevalence of cardiovascular diseases in patients with hypothyroidism]

F Mitu1, Elena Cojocaru, B Tamba

  • 1Universitatea de Medicină şi Farmacie "Grigore T. Popa" laşi Facultatea de Medicina.

Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi
|October 20, 2012
PubMed

Insights

Hypothyroidism significantly increases cardiovascular disease risk, including atherosclerosis. Early identification and lifestyle changes are crucial for managing cardiovascular health in these patients.

Area of Science:

  • Endocrinology
  • Cardiology
  • Public Health

Context:

  • Cardiovascular disease (CVD) risk is elevated in hypothyroidism due to functional abnormalities and atherosclerosis.
  • Subclinical and clinical hypothyroidism prevalence and associated CVD risk factors require investigation.

Purpose:

  • To examine the association between subclinical/clinical hypothyroidism and CVD.
  • To determine the prevalence of CVD risk factors in hypothyroid patients.

Summary:

  • A retrospective study of 64 hypothyroid patients revealed high rates of obesity (65.61%), hypertension (90.6%), and dyslipidemia (62.5%).
  • Subclinical thyroid dysfunction is prevalent, particularly in older adults.
  • Findings indicate a significant link between hypothyroidism and increased cardiovascular abnormalities and atherosclerosis.

Impact:

  • Earlier identification of hypothyroidism and subclinical atherosclerosis is vital.
  • Implementing lifestyle modifications can improve clinical outcomes.
  • This research underscores the importance of managing thyroid function for cardiovascular health.
Abstract

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...